ES2634763T3 - Enzimas para la transformación de ergopeptinas así como un procedimiento para ello - Google Patents
Enzimas para la transformación de ergopeptinas así como un procedimiento para ello Download PDFInfo
- Publication number
- ES2634763T3 ES2634763T3 ES13791893.4T ES13791893T ES2634763T3 ES 2634763 T3 ES2634763 T3 ES 2634763T3 ES 13791893 T ES13791893 T ES 13791893T ES 2634763 T3 ES2634763 T3 ES 2634763T3
- Authority
- ES
- Spain
- Prior art keywords
- enzymes
- transformation
- ergopeptinas
- procedure
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title abstract 3
- 108090000790 Enzymes Proteins 0.000 title abstract 3
- 230000009466 transformation Effects 0.000 title abstract 2
- LUMNWCHHXDUKFI-UHFFFAOYSA-N 5-bicyclo[2.2.1]hept-2-enylmethanol Chemical group C1C2C(CO)CC1C=C2 LUMNWCHHXDUKFI-UHFFFAOYSA-N 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
- C12P17/183—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing an indolo[4,3-F,G]quinoleine nucleus, e.g. compound containing the lysergic acid nucleus as well as the dimeric ergot nucleus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Enzimas para la transformación de ergopeptinas, especialmente para la escisión hidrolítica en el átomo C3' del anillo ciclol, caracterizadas porque las enzimas son α/ß-hidrolasas que tienen al menos un 96% de identidad de secuencia con la secuencia con nº de ID 1.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT10912012 | 2012-10-09 | ||
ATA1091/2012A AT513473B1 (de) | 2012-10-09 | 2012-10-09 | Enzyme zur Transformation von Ergopeptinen sowie Verfahren hierfür |
PCT/AT2013/000161 WO2014056006A1 (de) | 2012-10-09 | 2013-10-04 | Enzyme zur transformation von ergopeptinen sowie verfahren hierfür |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2634763T3 true ES2634763T3 (es) | 2017-09-28 |
Family
ID=49585222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES13791893.4T Active ES2634763T3 (es) | 2012-10-09 | 2013-10-04 | Enzimas para la transformación de ergopeptinas así como un procedimiento para ello |
Country Status (11)
Country | Link |
---|---|
US (1) | US9586990B2 (es) |
EP (1) | EP2906709B8 (es) |
CN (1) | CN104769124A (es) |
AT (1) | AT513473B1 (es) |
AU (1) | AU2013330204B2 (es) |
CA (1) | CA2885760C (es) |
DK (1) | DK2906709T3 (es) |
ES (1) | ES2634763T3 (es) |
HU (1) | HUE036358T2 (es) |
PL (1) | PL2906709T3 (es) |
WO (1) | WO2014056006A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2023003959A (es) | 2020-10-08 | 2023-05-25 | DSM Austria GmbH | Variantes de hidrolasa alfa/beta tetramerica con estabilidad a la temperatura incrementada y metodos de uso y produccion de las mismas. |
EP4263826A2 (en) | 2020-12-18 | 2023-10-25 | DSM Austria GmbH | Means and methods for detoxifying ochratoxin a |
EP4392552A1 (en) | 2021-08-27 | 2024-07-03 | DSM Austria GmbH | Means and methods for detoxifying ochratoxin a |
WO2025036933A1 (en) | 2023-08-17 | 2025-02-20 | Dsm Ip Assets B.V. | Means and methods for reducing estrogenic effect of xenoestrogen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1362876A (fr) * | 1963-07-08 | 1964-06-05 | Farmaceutici Italia | Nouveau procédé de préparation de l'acide lysergique |
WO2002029042A2 (en) * | 2000-10-05 | 2002-04-11 | Millennium Pharmaceuticals, Inc. | 48120, 23479, and 46689, novel human hydrolases and uses thereof |
-
2012
- 2012-10-09 AT ATA1091/2012A patent/AT513473B1/de not_active IP Right Cessation
-
2013
- 2013-10-04 AU AU2013330204A patent/AU2013330204B2/en active Active
- 2013-10-04 CA CA2885760A patent/CA2885760C/en active Active
- 2013-10-04 HU HUE13791893A patent/HUE036358T2/hu unknown
- 2013-10-04 ES ES13791893.4T patent/ES2634763T3/es active Active
- 2013-10-04 US US14/434,219 patent/US9586990B2/en active Active
- 2013-10-04 PL PL13791893T patent/PL2906709T3/pl unknown
- 2013-10-04 CN CN201380052664.6A patent/CN104769124A/zh active Pending
- 2013-10-04 EP EP13791893.4A patent/EP2906709B8/de active Active
- 2013-10-04 WO PCT/AT2013/000161 patent/WO2014056006A1/de active Application Filing
- 2013-10-04 DK DK13791893.4T patent/DK2906709T3/en active
Also Published As
Publication number | Publication date |
---|---|
CN104769124A (zh) | 2015-07-08 |
US9586990B2 (en) | 2017-03-07 |
EP2906709B1 (de) | 2017-06-21 |
AT513473A1 (de) | 2014-04-15 |
CA2885760A1 (en) | 2014-04-17 |
AU2013330204B2 (en) | 2017-06-01 |
CA2885760C (en) | 2018-04-17 |
AT513473B1 (de) | 2016-01-15 |
HUE036358T2 (hu) | 2018-07-30 |
EP2906709B8 (de) | 2017-08-02 |
PL2906709T3 (pl) | 2017-12-29 |
AU2013330204A1 (en) | 2015-04-02 |
EP2906709A1 (de) | 2015-08-19 |
US20150274775A1 (en) | 2015-10-01 |
WO2014056006A1 (de) | 2014-04-17 |
DK2906709T3 (en) | 2017-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34201A (es) | Compuestos de azaindol y métodos para el tratamiento de vih. | |
UY34765A (es) | Compuestos novedosos. | |
UY34697A (es) | Métodos para preparar análogos de nucleótidos | |
MX2016017355A (es) | Lipido que comprende acido docosapentaenoico. | |
UY34566A (es) | 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
UY34885A (es) | Proteínas de unión anti-mesotelina | |
UY34302A (es) | COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA | |
UY34593A (es) | Miméticos sintéticos de apelina para el tratamiento de falla cardiaca | |
UY34559A (es) | Inhibidores de bromodominios | |
UY34607A (es) | Plantas resistentes al glifosato y métodos asociados. | |
UY34515A (es) | Triazolopiridinas sustituidas | |
UY34817A (es) | Tienopirimidinas | |
UY4230Q (es) | Bocadillo retorcido para mascota | |
UY34467A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
UY34767A (es) | Inhibidores cíclicos del enlace éter de dgat1 | |
UY34034A (es) | Triazolopiridinas | |
UY34097A (es) | Alineación de anticoagulante de cebado para extracción de sangre. | |
UY34006A (es) | Imidazopiridazinas | |
UY34730A (es) | Formulaciones farmacéuticas que comprenden antagonistas de ccr3 | |
UY34442A (es) | 2-tiopirimidinonas. | |
PE20151435A1 (es) | Laquinimod para reducir el dano talamico en la esclerosis multiple | |
UY34629A (es) | Inhibidores de pirazolopirimidinilo de enzima activadora de ubicuitina | |
TR201905787T4 (tr) | Liyofilize TAT-NR2B9C formülasyonu. | |
UY34612A (es) | ?procedimiento para la preparación de derivados de isoxazolina azetidina quirales como agentes antiparasitarios?. | |
ES2634763T3 (es) | Enzimas para la transformación de ergopeptinas así como un procedimiento para ello |